Pertussis: microbiology, disease, treatment, and prevention

PE Kilgore, AM Salim, MJ Zervos… - Clinical microbiology …, 2016 - Am Soc Microbiol
Pertussis is a severe respiratory infection caused by Bordetella pertussis, and in 2008,
pertussis was associated with an estimated 16 million cases and 195,000 deaths globally …

Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies

S Mattoo, JD Cherry - Clinical microbiology reviews, 2005 - Am Soc Microbiol
Bordetella respiratory infections are common in people (B. pertussis) and in animals (B.
bronchiseptica). During the last two decades, much has been learned about the virulence …

[HTML][HTML] Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines …

KR Broder, MM Cortese, JK Iskander, K Kretsinger… - MMWR Recomm …, 2006 - cdc.gov
During spring 2005, two tetanus toxoid, reduced diphtheria toxoid and acellular pertussis
vaccine (Tdap) products formulated for use in adolescents (and, for one product, use in …

Pathology and Pathogenesis of Fatal Bordetella pertussis Infection in Infants

CD Paddock, GN Sanden, JD Cherry… - Clinical infectious …, 2008 - academic.oup.com
Abstract Background. Each year, Bordetella pertussis infection causes an estimated 294,000
deaths worldwide, primarily among young, nonvaccinated children. Approximately 90% of …

[PDF][PDF] Preventing tetanus, diphtheria, and pertussis among adults; use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: recommendations …

K Kretsinger, KR Broder, MM Cortese, P Joyce… - 2006 - cdc.gov
Summary On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid and acellular
pertussis vaccine (Tdap) formulated for use in adults and adolescents was licensed in the …

Pertussis disease burden in the household: how to protect young infants

SC de Greeff, FR Mooi, A Westerhof… - Clinical infectious …, 2010 - academic.oup.com
Background. We conducted a population-based, nation-wide, prospective study to identify
who introduced pertussis into the household of infants aged⩽ 6 months admitted to the …

Laboratory diagnosis of pertussis

A van der Zee, JFP Schellekens… - Clinical microbiology …, 2015 - Am Soc Microbiol
The introduction of vaccination in the 1950s significantly reduced the morbidity and mortality
of pertussis. However, since the 1990s, a resurgence of pertussis has been observed in …

Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women

BA Halperin, A Morris… - Clinical infectious …, 2011 - academic.oup.com
Abstract (See the Editorial Commentary by Munoz and Englund, on pages 893–6.)
Background. Because adolescents and adults act as a primary source of pertussis infection …

[HTML][HTML] Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants

TV Murphy, BA Slade, KR Broder, K Kretsinger… - MMWR Recomm …, 2008 - cdc.gov
In 2005, two tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap)
vaccines were licensed and recommended for use in adults and adolescents in the United …

[HTML][HTML] Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough

N Mielcarek, AS Debrie, D Raze, J Bertout… - PLoS …, 2006 - journals.plos.org
Pertussis is still among the principal causes of death worldwide, and its incidence is
increasing even in countries with high vaccine coverage. Although all age groups are …